SCHEMBL4979166

SCHEMBL4979166

CCC(CC)CN1C(=O)NC2(C(=O)Nc3ccc(C)cc32)C1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.39
POLB P06746 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
AKR1B1 P15121 2/20 0.39
ALDH1A1 P00352 4/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
ADAMTS5 Q9UNA0 2/20 0.34
GAA P10253 2/20 0.34
MGAM O43451 1/20 0.34
SI P14410 1/20 0.34
MGAM2 Q2M2H8 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
MAPT P10636 3/20 0.33
TSHR P16473 1/20 0.33
HTT P42858 1/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
ALOX12 P18054 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4979426 0.81 CNR1 (0.51) CYP1A2POLBCYP3A4CYP2C19AKR1B1
SCHEMBL4979970 0.81 AKR1B1 (0.41) CYP1A2POLBCYP3A4CYP2C19AKR1B1
SCHEMBL4263117 0.80 AKR1B1 (0.38) POLBCYP2C19AKR1B1ALDH1A1KMT2A
SCHEMBL4974510 0.79 CNR1 (0.49) CYP1A2POLBCYP3A4CYP2C19AKR1B1
SCHEMBL3953441 0.76 CYP1A2 (0.40) CYP1A2POLBCYP3A4CYP2C19AKR1B1
SCHEMBL4979296 0.74 AKR1B1 (0.41) CYP1A2CYP2C19AKR1B1ALDH1A1KMT2A
SCHEMBL4979616 0.74 KMT2A (0.37) CYP1A2POLBCYP3A4CYP2C19AKR1B1
SCHEMBL4979162 0.73 CYP1A2 (0.42) CYP1A2POLBCYP3A4CYP2C19AKR1B1
SCHEMBL4976844 0.73 KMT2A (0.38) CYP1A2POLBCYP3A4CYP2C19AKR1B1
SCHEMBL4977919 0.72 KMT2A (0.40) POLBCYP3A4CYP2C19ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1984374-A1 USE OF SPIRO Ý IMIDAZOLIDINE-4, 3'-INDOLE¨2, 2', 5' (1H) TRIONES FOR TREATMENT OF CONDITIONS ASSOCIATED WITH VANILLOID RECEPTOR 1 AstraZeneca AB (SE) 2008-10-29 EP disclosed
WO-2007091946-A1 USE OF SPIRO [ IMIDAZOLIDINE-4, 3'-INDOLE] 2, 2', 5' (1H) TRIONES FOR TREATMENT OF CONDITIONS ASSOCIATED WITH VANILLOID RECEPTOR 1 ASTRAZENECA AB (SE) 2007-08-16 WO disclosed